EXO1 and neoplasm: There was no clear evidence for loss of the wild-type allele in the remaining samples from tumour DNA from carriers of FANCC or EXO1. However, loss of the variant allele was observed in the tumour DNA from FANCC and EXO1 variant carriers (Table S7).